Children’s Hospital of Wisconsin raises the bar in pediatric cancer treatment and research

It’s not every day that a pediatric Phase 1 Clinical Trial Center opens in Wisconsin. In fact, the Oncology Program at Children’s Hospital of Wisconsin is the only Children’s Oncology Group Phase 1 and Pilot Consortium in the entire state and one of only 21 centers in the world. That puts us in an elite group of pediatric cancer programs and raises the bar for research in the state.

So what does this really mean for the children and families who come through our doors?

  • Children treated here benefit from cutting-edge therapies when traditional treatments have been exhausted.
  • Children and their families can stay right here in Milwaukee with their trusted doctors and nurses to participate in a clinical study. Previously children and their families would have to relocate to participate in these studies.
  • Information gathered by the consortium contributes to the development of new therapies and adds to the understanding of childhood cancer around the world.

A heartfelt thank you to the MACC Fund for their support in developing the infrastructure needed to run these early clinical trials. It’s a great thing when we know we are offering our children the best possible treatment options.

Michael Kelly, MD~ Michael Kelly, MD, PhD, Children’s Hospital of Wisconsin

Dr. Kelly is part of the multidisciplinary oncology team at Children’s Hospital of Wisconsin that diagnoses and treats childhood cancers. Founded in 1974, our Oncology Program is an active member of Children’s Oncology Group, an organization dedicated to studying childhood cancers.

Comments are closed.